Ten year survival after heart transplantation: Palliative procedure or successful long term treatment?

Heart

Volumn 82, Issue 1, 1999, Pages 47-51

  Fraund, S ^a   Pethig, K ^a   Franke, U ^a   Wahlers, T ^a   Harringer, W ^a   Cremer, J ^a   Fieguth, H G ^a   Oppelt, P ^a   Haverich, A ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Heart transplantation; Long term survival

Indexed keywords

CREATININE;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME;

EID: 0033060616     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.82.1.47     Document Type: Article

References (31)

1. 1 Franciosa JA, Wilen M, Ziesche S, et al. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983;51:831-6.
2. 2 Fuster V, Gersh B, Giuliani E, et al. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1983;51:831-6.
3. 3 McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-6.
4. 4 Cohn JN, Franciosa JA. Vasodilator therapy of cardiac failure. N Engl J Med 1977;297:27-31;254-8.
5. 5 Cohn JN, Archibald DG, Ziescher S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration cooperative study (V-HeftI). N Engl J Med 1986;14:1547-52.
6. 6 The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the cooperative north Scandinavian enalapril survival study (CONSENSUS). N Engl J Med 1987;316:1429-35.
7. 7 Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-10.
8. 8 O'Connell JB, Bourge RC, Costanzo-Nordin MR, et al. Cardiac transplantation: recipient selection, donor procurement, and medical follow up. A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1992;86:1061-79.
9. 9 Oyer PE. Heart transplantation in the cyclosporine era. Ann Thorac Surg 1988;46:489-90.
10. 10 Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991;325:1468-75.
11. 11 Hosenpud JD, Novick RJ, Bennett LE, et al. The registry of the International Society for Heart and Lung Transplantation: official report-1996. J Heart Lung Transplant 1996;15:655-74.
12. 12 Smith WM. Epidemiology of congestive heart failure. Am J Cardiol 1985;55(suppl):3-8.
13. 13 Frist WH, Stinson EB, Oyer PE, et al. Long-term hemodynamic results after cardiac transplantation. J Thorac Cardiovasc Surg 1987;94:685-93.
14. 14 von Scheidt W, Ziegler B, Kemkes BM, et al. Long-term myocardial function after heart transplantation. Thorac Cardiovasc Surg 1993;41:156-62.
15. 15 Gao SZ, Aldermann EL, Schroeder JS, et al. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriography findings. J Am Coll Cardiol 1988;12:334-40.
16. 16 Johnson DE, Gao SZ, Schroeder JS, et al. The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant 1989,8:349-59.
17. 17 Schroeder JS, Hunt SA. Cardiac transplantation: where are we? N Engl J Med 1986;315:961-3.
18. 18 Miller LW. Allograft coronary artery disease. Heart Failure 1989;5:253-9.
19. 19 Klauss V, Ackermann K, Hennecke KH, et al. Epicardial intimal thickening in transplant coronary artery disease and resistance vessel response to adenosine. Circulation 1997;96(suppl II):II-1564.
20. 20 Chenzbraun A, Pinto F, Alderman E, et al. Distribution and morphologic features of coronary artery disease in cardiac allografts: an intracoronary ultrasound study. J Am Soc Echocardiogr 1995;8:1-8.
21. 21 Pethig K, Heublein B, Wahlers T, et al. Mechanism of luminal narrowing in cardiac allograft vasculopathy: inadequate remodeling rather than intimal hyperplasia is the major predictor of coronary artery stenosis. Am Heart J 1998;135:628-33.
22. 22 Gao SZ, Schroeder J, Alderman E, et al. Incidence of accelerated coronary artery disease in heart transplant survivors: comparison of cyclosporine and azathioprine regimen [abstract]. Circulation 1988;78(suppl II):280.
23. 23 Ratkovec RM, Wray RB, Renlund DG, et al. Influence of corticosteroid-free maintenance immunosuppression in allograft coronary artery disease after cardiac transplantation. J Thorac Cardiovasc Surg 1990;100:6-12.
24. 24 Kobashigawa JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcome after cardiac transplantation. N Engl J Med 1995;333:621-7.
25. 25 Schroeder JS, Gao SZ, Alderman EL, et al. Prevention of transplant accelerated coronary vascular disease with diltiazem. J Am Coll Cardiol 1994;91:1647-54.
26. 26 Hausen B, Demertzis S, Rohde R, et al. Low-dose cyclosporine therapy in triple-drug immunosuppression for heart transplant recipients. Ann Thorac Surg 1994;58:999-1004.
27. 27 Penn I. Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 1993;12:328-36.
28. 28 Pethig K, Fischer H, Wahlers T, et al. Todesursachen nach Herztransplantation: Einfluss auf die klinische Langzeitbetreuung. Z Kardiol 1997;86:S3,98.
29. 29 Bourge CR, Kirklin JK, Naftel DC, et al. Predicting outcome after cardiac transplantation: lessons from the cardiac transplant research database. Curr Opin Cardiol 1997;12:136-45.
30. 30 De Mattos AM, Head MA, Everett J, et al. HLA-DR mismatching correlates with early cardiac allograft rejection, incidence, and graft survival when high confidence level serological DR typing is used. Transplantation 1994;54:626-30.
31. 31 Smith DJ, Rose ML, Pomerance A, et al. Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching. Lancet 1995;346:1318-22.